Air Tamponade Versus Fluorinated Gas Tamponade for Rhegmatogenous Retinal Detachment

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorLiverpool University Hospitals NHS Foundation Trust

About this trial

TITLE: RCT of air tamponade versus fluorinated gas tamponade for rhegmatogenous retinal detachment DESIGN: Non-inferiority RCT of 150 patients from 10 UK centres AIMS: To assess whether air tamponade is non inferior to gas tamponade for the repair of RRD treated with vitrectomy.

PRIMARY OUTCOME MEASURE: Primary anatomical success with single operation at 24 weeks.

Eligibility criteria

Qualifiers

Primary uncomplicated RRD undergoing vitrectomy.

Phakic and pseudophakic eyes

Retinal breaks superiorly between 3 and 9 o'clock, and that are separated by less than 4 clock hours.

Disqualifiers

Absence of PVD

Age 40 years or younger

PVR grade C or above

Aphakia or anterior chamber lens

Trial design

Treatments tested in this trial

  • air
  • Gas SF6 (Sulfur Hexafluoride) and others

Treatment groups

150 Participants
are divided into 2 treatment groups

Locations

This trial has no locations